Delivery Order SPE2DR25D3006-SPE2DR26FR0RF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,945.40 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract was issued under a non-set-aside procurement and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a task order against AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $1,750.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count units) on January 20, 2026, with completion scheduled for January 21, 2026. The contract was awarded without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,270.24 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg, with a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,392.78 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,258.76 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a $1,136.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg, with performance in Conshohocken, Pennsylvania and completion targeted for January 21, 2026. This is a non-set-aside competitive award issued on January 20, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,039.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,879.96 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,954.77 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D3006Indefinite Delivery Contract
- SPE2DR25D3006-SPE2DR26FR0RFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,068.94 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order, with performance in Conshohocken, Pennsylvania, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and medical devices across multiple therapeutic domains. The DLA-administered contract demonstrates the company's established capability to meet federal pharmaceutical procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/1/26 |